FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver

被引:29
|
作者
Dhar, DK [1 ]
Takemoto, Y [1 ]
Nagasue, N [1 ]
Uchida, M [1 ]
Ono, T [1 ]
Nakamura, T [1 ]
机构
[1] SHIMANE MED UNIV,DEPT SURG 2,IZUMO,SHIMANE 693,JAPAN
关键词
D O I
10.1006/jsre.1996.0023
中图分类号
R61 [外科手术学];
学科分类号
摘要
Increased morbidity and mortality following transplantation surgery due to the primary nonfunction and dysfunction of the liver poses a great challenge and has increased the crescendo of research work in this field. In this study, we have tried to address the issue concerning the changes in Ca2+ homeostasis and hepatic microcirculation in 90 min of ischemia followed by reperfusion of the liver after FK506 pretreatment. Twenty dogs divided into two groups; group I (0.15 mg/kg/day FK506 for 3 days, im) and group II (control) were used for the measurement of mitochondrial (mit) and total cellular Ca2+ by atomic absorption spectrophotometer and hepatic microcirculation with laser Doppler flowmeter. Serum AST leakage was significantly (P < 0.05) suppressed in group I at 6 hr after reperfusion. The percentage gain in mit Ca2+ in group I was significantly (P < 0.05) inhibited compared to that in group II at 15 min after reperfusion and also when compared with the preischemic value it was significantly (P < 0.05) elevated at 30 min after reperfusion in group II only. FK pretreatment significantly (P < 0.05) inhibited the overload in total cellular Ca2+ at 15 and 30 min after reperfusion. Moreover, hepatic microcirculation was significantly (P < 0.001) better in group I between 2 and 6 hr after reperfusion. In conclusion, the ameliorating property of FK in ischemia-reperfusion may be explained by prevention of the cellular Ca2+ overload during the perireperfusion period. (C) 1996 Academic Press, Inc.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [1] THE SALUTARY EFFECT OF FK506 IN ISCHEMIA-REPERFUSION INJURY OF THE CANINE LIVER
    DHAR, DK
    NAGASUE, N
    KIMOTO, T
    UCHIDA, M
    TAKEMOTO, Y
    NAKAMURA, T
    TRANSPLANTATION, 1992, 54 (04) : 583 - 588
  • [3] Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506
    Ishii, Takayuki
    Asai, Tomohiro
    Oyama, Dai
    Agato, Yurika
    Yasuda, Nodoka
    Fukuta, Tatsuya
    Shimizu, Kosuke
    Minamino, Tetsuo
    Oku, Naoto
    FASEB JOURNAL, 2013, 27 (04): : 1362 - 1370
  • [4] THE EFFECT OF FK506 ON WARM ISCHEMIA AND REPERFUSION INJURY IN THE RAT-LIVER
    WAKABAYASHI, H
    KARASAWA, Y
    TANAKA, S
    KOKUDO, Y
    MAEBA, T
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (11): : 994 - 1002
  • [5] Pre-treatment with FK506 reduces hepatic ischemia-reperfusion injury in rats
    Chen, Feng
    Zhang, Ya-min
    Wang, Jing-tao
    Wang, Jian
    Cui, Zi-lin
    Liu, Zi-rong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (02) : 161 - 170
  • [6] Experimental Studies on Protective Effects of FK506 Against Hepatic Ischemia-Reperfusion Injury
    Sawada, Toshihiko
    Inoue, Katsuhiko
    Tanabe, Dairou
    Kawamoto, Shunji
    Tsuji, Tatsuya
    Tashiro, Seiki
    JOURNAL OF MEDICAL INVESTIGATION, 2016, 63 (3-4): : 262 - 269
  • [8] AMELIORATIVE EFFECT OF FK-506 ON COLD ISCHEMIA-REPERFUSION INJURY OF THE RAT-LIVER
    OKANO, K
    HAMAMOTO, I
    IZUISHI, K
    WAKABAYASHI, H
    AKRAM, HM
    MAEBA, T
    TANAKA, S
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 2367 - 2369
  • [9] NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY - MODULATING EFFECTS OF FK506 AND CYCLOSPORINE
    SUZUKI, S
    TOLEDOPEREYRA, LH
    RODRIGUEZ, FJ
    CEJALVO, D
    TRANSPLANTATION, 1993, 55 (06) : 1265 - 1272
  • [10] Does FK506 improve lung ischemia/reperfusion injury after lung transplantation?
    Sugita, M
    Ferraro, P
    Van Spall, M
    Berthiaume, Y
    FASEB JOURNAL, 2003, 17 (04): : A421 - A421